ALE1Recent news mentioning ALE12026-08-18 — BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's PipelineAppears alongsideBioMarinBrowse the full archive →